Clinical Trial Update: The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D [NA]

View source ↗

Summary

A completed clinical trial from University Hospital Gentofte explores the role of GLP-1 receptor signaling in mediating the glucose-lowering effect of metformin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Glucose Metabolism Disorders | NA | Status: COMPLETED